Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 10 studies | 40% ± 23% | |
endothelial cell | 9 studies | 25% ± 10% | |
oligodendrocyte precursor cell | 9 studies | 28% ± 11% | |
GABAergic neuron | 7 studies | 43% ± 18% | |
neuron | 6 studies | 34% ± 17% | |
interneuron | 6 studies | 42% ± 16% | |
macrophage | 6 studies | 27% ± 2% | |
astrocyte | 5 studies | 24% ± 11% | |
epithelial cell | 4 studies | 36% ± 14% | |
GABAergic interneuron | 3 studies | 25% ± 10% | |
microglial cell | 3 studies | 19% ± 3% | |
progenitor cell | 3 studies | 27% ± 6% | |
retinal cone cell | 3 studies | 24% ± 8% | |
fibroblast | 3 studies | 24% ± 6% | |
basal cell | 3 studies | 33% ± 21% | |
adipocyte | 3 studies | 17% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 32% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1162.73 | 245 / 245 | 100% | 10.02 | 500 / 502 |
bladder | 100% | 1571.00 | 21 / 21 | 99% | 8.54 | 499 / 504 |
lung | 100% | 1002.54 | 576 / 578 | 99% | 7.44 | 1147 / 1155 |
esophagus | 100% | 1419.16 | 1445 / 1445 | 99% | 8.01 | 181 / 183 |
breast | 100% | 1397.03 | 459 / 459 | 97% | 7.96 | 1089 / 1118 |
pancreas | 98% | 572.96 | 322 / 328 | 99% | 9.30 | 176 / 178 |
stomach | 100% | 943.67 | 359 / 359 | 97% | 6.38 | 277 / 286 |
intestine | 100% | 1198.92 | 966 / 966 | 97% | 6.48 | 510 / 527 |
thymus | 100% | 1079.87 | 652 / 653 | 97% | 7.29 | 585 / 605 |
kidney | 100% | 658.98 | 89 / 89 | 96% | 6.74 | 864 / 901 |
uterus | 100% | 1184.48 | 170 / 170 | 96% | 8.55 | 440 / 459 |
ovary | 100% | 924.32 | 180 / 180 | 95% | 5.70 | 409 / 430 |
brain | 93% | 766.49 | 2451 / 2642 | 99% | 7.81 | 701 / 705 |
adrenal gland | 99% | 551.12 | 255 / 258 | 90% | 6.15 | 208 / 230 |
skin | 100% | 2953.37 | 1809 / 1809 | 89% | 5.93 | 421 / 472 |
liver | 100% | 531.02 | 226 / 226 | 83% | 3.85 | 336 / 406 |
adipose | 100% | 1415.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 772.05 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.30 | 1 / 1 |
blood vessel | 100% | 836.69 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 628.43 | 796 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 8.02 | 44 / 45 |
heart | 93% | 451.28 | 800 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 2.35 | 22 / 29 |
eye | 0% | 0 | 0 / 0 | 65% | 2.81 | 52 / 80 |
peripheral blood | 9% | 32.80 | 88 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042475 | Biological process | odontogenesis of dentin-containing tooth |
GO_0007498 | Biological process | mesoderm development |
GO_0032924 | Biological process | activin receptor signaling pathway |
GO_0007178 | Biological process | cell surface receptor protein serine/threonine kinase signaling pathway |
GO_0007283 | Biological process | spermatogenesis |
GO_0071773 | Biological process | cellular response to BMP stimulus |
GO_0045428 | Biological process | regulation of nitric oxide biosynthetic process |
GO_0007368 | Biological process | determination of left/right symmetry |
GO_0060391 | Biological process | positive regulation of SMAD protein signal transduction |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0042713 | Biological process | sperm ejaculation |
GO_0032927 | Biological process | positive regulation of activin receptor signaling pathway |
GO_0071363 | Biological process | cellular response to growth factor stimulus |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0043084 | Biological process | penile erection |
GO_0030509 | Biological process | BMP signaling pathway |
GO_0060011 | Biological process | Sertoli cell proliferation |
GO_0048706 | Biological process | embryonic skeletal system development |
GO_0009952 | Biological process | anterior/posterior pattern specification |
GO_0045648 | Biological process | positive regulation of erythrocyte differentiation |
GO_0006468 | Biological process | protein phosphorylation |
GO_0030501 | Biological process | positive regulation of bone mineralization |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0001702 | Biological process | gastrulation with mouth forming second |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0034673 | Cellular component | inhibin-betaglycan-ActRII complex |
GO_0009986 | Cellular component | cell surface |
GO_0005737 | Cellular component | cytoplasm |
GO_0048179 | Cellular component | activin receptor complex |
GO_0015026 | Molecular function | coreceptor activity |
GO_0098821 | Molecular function | BMP receptor activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0048185 | Molecular function | activin binding |
GO_0030165 | Molecular function | PDZ domain binding |
GO_0004675 | Molecular function | transmembrane receptor protein serine/threonine kinase activity |
GO_0017002 | Molecular function | activin receptor activity |
GO_0019838 | Molecular function | growth factor binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0034711 | Molecular function | inhibin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ACVR2A |
Protein name | Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA) |
Synonyms | ACVR2 |
Description | FUNCTION: On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin A, activin B and inhibin A . Mediates induction of adipogenesis by GDF6 (By similarity). . |
Accessions | ENST00000241416.12 [P27037-1] ENST00000404590.1 [P27037-1] P27037 ENST00000535787.5 [P27037-2] |